×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Equine Healthcare Market

ID: MRFR/HC/50667-HCR
200 Pages
Rahul Gotadki
October 2025

China Equine Healthcare Market Research Report: Size, Share, Trend Analysis By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others), By Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Others), By Activity (Sports/Racing, Recreation, Others) and By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others) - Growth Outlook & Industry Forecast 2025 T... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Equine Healthcare Market Infographic
Purchase Options

China Equine Healthcare Market Summary

As per Market Research Future analysis, the equine healthcare market size was estimated at 155.63 USD Million in 2024. The equine healthcare market is projected to grow from 166.21 USD Million in 2025 to 320.84 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 6% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The China equine healthcare market is experiencing robust growth driven by evolving consumer preferences and technological advancements.

  • The market is witnessing a rise in preventive care as horse owners increasingly prioritize health maintenance.
  • Integration of technology in veterinary practices is enhancing service delivery and efficiency in equine healthcare.
  • Demand for specialized services is growing, particularly in the largest segment of equine veterinary care.
  • Key market drivers include increasing horse ownership and rising awareness of equine health, which are propelling market expansion.

Market Size & Forecast

2024 Market Size 155.63 (USD Million)
2035 Market Size 320.84 (USD Million)
CAGR (2025 - 2035) 6.8%

Major Players

Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US), Patterson Companies (US)

China Equine Healthcare Market Trends

The equine healthcare market is experiencing notable growth, driven by increasing awareness of animal welfare and advancements in veterinary medicine. In recent years, there has been a marked shift towards preventive care, with horse owners prioritizing regular health check-ups and vaccinations. This trend reflects a broader societal change, where the health of equines is viewed as integral to their performance and well-being. Additionally, the rise of digital technologies in veterinary practices is enhancing service delivery, allowing for more efficient diagnostics and treatment plans. As a result, the equine healthcare market is becoming more accessible and responsive to the needs of horse owners. Moreover, the demand for specialized equine healthcare services is on the rise, as owners seek tailored solutions for their animals. This includes nutritional counseling, alternative therapies, and rehabilitation services. The increasing participation in equestrian sports and recreational riding further fuels this demand, as owners are more invested in the health and performance of their horses. Consequently, the equine healthcare market is evolving, with a focus on comprehensive care that addresses both physical and mental health aspects of equines. The future appears promising, with ongoing innovations likely to shape the landscape of equine healthcare in the coming years.

Rise of Preventive Care

There is a growing emphasis on preventive care within the equine healthcare market. Horse owners are increasingly recognizing the importance of regular health check-ups and vaccinations to maintain their animals' well-being. This trend indicates a shift towards proactive management of equine health, which may lead to improved outcomes and reduced long-term costs.

Integration of Technology

The integration of technology into veterinary practices is transforming the equine healthcare market. Digital tools are enhancing diagnostics and treatment processes, making them more efficient and effective. This technological advancement could potentially improve the overall quality of care provided to equines, benefiting both owners and veterinarians.

Demand for Specialized Services

There is a noticeable increase in demand for specialized services within the equine healthcare market. Owners are seeking tailored solutions, including nutritional advice and alternative therapies, to address the unique needs of their horses. This trend suggests a more holistic approach to equine health, focusing on both physical and mental well-being.

China Equine Healthcare Market Drivers

Increasing Horse Ownership

The equine healthcare market in China is experiencing growth due to a notable increase in horse ownership. As more individuals and families invest in horses for recreational and competitive purposes, the demand for healthcare services rises. This trend is particularly evident in urban areas where equestrian sports are gaining popularity. The number of registered horses in China has reportedly increased by approximately 15% over the past five years, indicating a burgeoning interest in equine activities. Consequently, this surge in horse ownership necessitates a corresponding rise in veterinary services, nutritional products, and preventive care, thereby driving the equine healthcare market. The industry is likely to see further expansion as awareness of equine health issues grows among new owners.

Growth of Equestrian Sports

The increasing popularity of equestrian sports in China is significantly contributing to the growth of the equine healthcare market. As more individuals participate in competitive riding, dressage, and show jumping, the need for specialized healthcare services becomes apparent. This trend is supported by the establishment of more equestrian clubs and training facilities across the country. The rise in competitive events has led to a greater focus on the health and performance of horses, prompting owners to invest in comprehensive healthcare solutions. Consequently, the equine healthcare market is likely to benefit from this trend, as the demand for specialized veterinary care, nutrition, and performance-enhancing products continues to grow.

Government Support and Regulation

Government initiatives aimed at promoting animal welfare and the equine industry are significantly influencing the equine healthcare market in China. Recent policies have been introduced to enhance veterinary services and ensure the health of horses, which is crucial for both recreational and competitive sectors. The Chinese government has allocated funding to improve veterinary education and training, which is expected to elevate the standards of care available. Furthermore, regulations surrounding equine health and safety are becoming more stringent, compelling owners to seek professional healthcare services. This regulatory environment not only fosters a more responsible approach to horse ownership but also stimulates growth in the equine healthcare market as compliance with these regulations becomes essential.

Rising Awareness of Equine Health

There is a growing awareness of equine health issues among horse owners in China, which is positively impacting the equine healthcare market. Educational campaigns and increased access to information about horse care have led to a more informed public. Owners are now more likely to seek veterinary services for routine check-ups, vaccinations, and specialized treatments. This shift in mindset is reflected in the rising expenditure on equine healthcare, with reports indicating that spending on veterinary services has increased by approximately 20% in recent years. As owners prioritize the health and well-being of their horses, the demand for high-quality healthcare products and services is expected to continue to rise, further propelling the equine healthcare market.

Advancements in Veterinary Technology

Technological advancements in veterinary medicine are playing a crucial role in shaping the equine healthcare market in China. Innovations such as telemedicine, advanced diagnostic tools, and minimally invasive surgical techniques are enhancing the quality of care available to horses. These technologies not only improve treatment outcomes but also make veterinary services more accessible to horse owners in remote areas. The integration of technology into equine healthcare practices is likely to attract more clients, as owners seek the best possible care for their animals. As the industry adapts to these advancements, the equine healthcare market is expected to expand, driven by the demand for cutting-edge veterinary solutions.

Market Segment Insights

China Equine Healthcare Market Segment Insights

China Equine Healthcare Market Segment Insights

Equine Healthcare Market Product Insights

Equine Healthcare Market Product Insights

The China Equine Healthcare Market is projected to experience considerable growth, primarily driven by increasing awareness and investment in equine health and wellness. The Product segment plays a vital role in this market, comprising several key categories that contribute to overall market dynamics. Vaccines have been vital in preventing diseases, protecting horses from a variety of infections, thereby establishing a baseline for proper equine care. Pharmaceuticals represent another significant component, encompassing a wide range of treatments that address various health issues in horses, emphasizing the need for specialized medications in the industry.

Medicinal Feed Additives are increasingly recognized for their importance in enhancing equine nutrition and overall health, which in turn supports performance and well-being in competitive horses. This segment reflects a growing trend towards improving equine diets through scientifically formulated products. Diagnostics plays a crucial role by enabling accurate disease detection and monitoring, ensuring timely treatment interventions, which essential in efficient equine healthcare management. The integration of advanced diagnostics tools has significantly improved clinical outcomes, making it a pivotal area of development within the market.

Software and Services related to equine healthcare are gaining traction as technology adoption rises within the industry. These solutions enhance practice management and improve client communications, reflecting a shift toward data-driven decision making in veterinary practice. This not only supports veterinarians in delivering better care but also assists owners in maintaining optimal health for their horses.

Additionally, the "Others" category within the Product segment encompasses various innovative solutions that support horse management and welfare, further diversifying the market landscape. Overall, the China Equine Healthcare Market segmentation illustrates a robust and evolving sector with increasing demand for advanced healthcare solutions that prioritize equine health and performance, highlighting important trends and growth drivers including rising disposable income, owner awareness, and regulatory support for animal health initiatives.

Equine Healthcare Market Indication Insights

Equine Healthcare Market Indication Insights

The China Equine Healthcare Market exhibits significant growth potential in the Indication segment, driven by the rising awareness of equine health across the region. As China's equine population continues to expand, the demand for products addressing Musculoskeletal Disorders has gained prominence, given the physical activities and strenuous demands placed on these animals. The focus on Parasite Control remains critical, as equine parasites pose substantial health risks affecting productivity and performance. 

Internal Medicine plays a vital role in diagnosing and treating various illnesses, where improved veterinary practices are instrumental in enhancing animal welfare.Moreover, infectious diseases like Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, and West Nile Virus are pivotal concerns that underscore the necessity for effective treatments and vaccines. Tetanus, while less common, is a serious threat that requires ongoing attention in equine healthcare. 

Each of these areas represents a crucial aspect of the overall health and management of equines, reflecting the broader trends within the China Equine Healthcare Market where advancements and innovations are shaping the industry landscape.The market continues to evolve, influenced by regulatory changes and a growing emphasis on research and education within veterinary practices.

Equine Healthcare Market Activity Insights

Equine Healthcare Market Activity Insights

The Activity segment within the China Equine Healthcare Market is characterized by its dynamic growth and diversification. This segment encompasses various aspects including Sports/Racing, Recreation, and Others which collectively contribute to the overall health and well-being of equines in China. Sports and racing hold considerable significance in the country, driven by a growing interest in equine competitions and events, coupled with increased investments in sport-related equine care. 

The recreational activities involving horses are also gaining momentum, with more urban populations engaging in leisure activities such as horseback riding, leading to increased demand for preventive healthcare and wellness products.Additionally, the Others category encompasses various niche areas, which are vital for expanding services and product offerings tailored to specific consumer needs, further enhancing market penetration. The robust growth drivers include rising disposable income, shifting lifestyle preferences, and heightened awareness regarding equine welfare, creating a favorable environment for innovations in the sector. 

With trends indicating a strong focus on specialized care and health monitoring solutions for performance horses, the Activity segment is poised to play a pivotal role in shaping the future of the China Equine Healthcare Market.

Equine Healthcare Market Distribution Channel Insights

Equine Healthcare Market Distribution Channel Insights

The Distribution Channel segment of the China Equine Healthcare Market plays a crucial role in delivering essential products and services to horse owners and professionals across the country. Veterinary Hospitals and Clinics are significant players in this segment, as they provide specialized healthcare services, diagnostics, and treatments tailored to equine needs, thereby establishing trust and long-term relationships with clients. E-commerce has gained notable traction, driven by the increasing digitalization of the healthcare sector and the convenience it offers horse owners in purchasing medications, supplements, and healthcare products from the comfort of their homes.

This shift towards online shopping is further enhanced by the growing number of pet ownership in urban areas of China. The Others category encompasses alternative distribution methods, which include retail pharmacies and agricultural supply stores, catering to a diverse clientele. This multifaceted approach ensures that various customer preferences are met, and it highlights the dynamic nature of the China Equine Healthcare Market. Collectively, these channels contribute to increasing access to equine healthcare solutions, ultimately supporting better health outcomes for horses throughout the region.

Get more detailed insights about China Equine Healthcare Market

Key Players and Competitive Insights

The equine healthcare market in China is characterized by a dynamic competitive landscape, driven by increasing awareness of equine health and rising investments in veterinary services. Key players such as Merck Animal Health (US), Zoetis (US), and Boehringer Ingelheim (DE) are strategically positioned to leverage innovation and expand their market presence. Merck Animal Health (US) focuses on developing advanced vaccines and therapeutics, while Zoetis (US) emphasizes digital health solutions and data analytics to enhance veterinary care. Boehringer Ingelheim (DE) is known for its commitment to research and development, particularly in equine vaccines, which collectively shapes a competitive environment that prioritizes innovation and customer-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure allows for a diverse range of products and services, catering to the varying needs of equine healthcare providers and horse owners.

In October 2025, Merck Animal Health (US) announced the launch of a new equine vaccine aimed at combating a prevalent respiratory disease in horses. This strategic move is significant as it not only addresses a critical health issue but also reinforces Merck's commitment to innovation in equine health. The introduction of this vaccine is likely to enhance the company's market position and strengthen its relationships with veterinarians and horse owners alike.

In September 2025, Zoetis (US) unveiled a digital platform designed to streamline veterinary practices and improve client communication. This initiative reflects a growing trend towards digitalization in the equine healthcare sector, suggesting that Zoetis is keen on integrating technology into its service offerings. By enhancing operational efficiency and client engagement, Zoetis may solidify its competitive edge in a rapidly evolving market.

In August 2025, Boehringer Ingelheim (DE) expanded its research facilities in China, focusing on equine health solutions. This expansion indicates a long-term commitment to the region and a strategic effort to enhance its R&D capabilities. By investing in local infrastructure, Boehringer Ingelheim is likely to accelerate the development of innovative products tailored to the specific needs of the Chinese equine market.

As of November 2025, current trends in the equine healthcare market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence in veterinary practices. Strategic alliances among key players are shaping the competitive landscape, fostering collaboration that enhances product offerings and market reach. Looking ahead, competitive differentiation is expected to evolve, with a notable shift from price-based competition to a focus on innovation, technology, and supply chain reliability. This transition may redefine how companies engage with customers and position themselves in the market.

Key Companies in the China Equine Healthcare Market market include

Industry Developments

Recent developments in the China Equine Healthcare Market have been noteworthy, particularly with companies focusing on expanding their product offerings and strengthening their market position. Neogen has been enhancing its portfolio through innovative healthcare solutions, while Zoetis has introduced advanced vaccines tailored for disease prevention in equine. In terms of mergers and acquisitions, there have been significant movements; for instance, in June 2023, Boehringer Ingelheim announced a strategic acquisition to bolster its veterinary pharmaceutical capabilities in China, a move that is expected to enhance its product distribution and local expertise. 

This aligns with the growing trend of consolidation within the market as companies look to leverage synergies. The healthcare market for equines in China is also witnessing a rise in investments driven by an increase in the population of specialized horses, reflecting a projected growth in market valuation, which is also attributed to heightened awareness of equine health. The overall impact of these developments is propelling the market forward, with major players like Elanco Animal Health and Merck Animal Health continuously adapting to meet evolving regulatory standards and consumer needs in the region.

Future Outlook

China Equine Healthcare Market Future Outlook

The Equine Healthcare Market in China is projected to grow at a 6.8% CAGR from 2024 to 2035, driven by increasing equine population, rising awareness of health, and advancements in veterinary technology.

New opportunities lie in:

  • Development of telemedicine platforms for remote veterinary consultations.
  • Expansion of specialized equine nutrition products targeting performance horses.
  • Implementation of integrated health management software for equine facilities.

By 2035, the equine healthcare market is expected to achieve substantial growth and innovation.

Market Segmentation

China Equine Healthcare Market Product Outlook

  • Vaccines
  • Pharmaceuticals
  • Medicinal Feed Additives
  • Diagnostics
  • Software & Services
  • Others

China Equine Healthcare Market Activity Outlook

  • Sports/Racing
  • Recreation
  • Others

China Equine Healthcare Market Indication Outlook

  • Musculoskeletal Disorders
  • Parasite Control
  • Internal Medicine
  • Equine Herpes Virus
  • Equine Encephalomyelitis
  • Equine Influenza
  • West Nile Virus
  • Tetanus
  • Others

China Equine Healthcare Market Distribution Channel Outlook

  • Veterinary Hospitals & Clinics
  • E-commerce
  • Others

Report Scope

MARKET SIZE 2024 155.63(USD Million)
MARKET SIZE 2025 166.21(USD Million)
MARKET SIZE 2035 320.84(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.8% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Merck Animal Health (US), Zoetis (US), Boehringer Ingelheim (DE), Elanco Animal Health (US), Virbac (FR), Dechra Pharmaceuticals (GB), Vetoquinol (FR), Heska Corporation (US), Patterson Companies (US)
Segments Covered Product, Indication, Activity, Distribution Channel
Key Market Opportunities Integration of telemedicine and digital health solutions in the equine healthcare market.
Key Market Dynamics Rising demand for advanced veterinary services drives innovation in equine healthcare solutions across the region.
Countries Covered China

Leave a Comment

FAQs

What is the projected market size of the China Equine Healthcare Market in 2024?

The China Equine Healthcare Market is expected to be valued at 155.4 million USD in 2024.

What is the anticipated market size of the China Equine Healthcare Market by 2035?

By 2035, the overall market is expected to grow significantly to a valuation of 931.8 million USD.

What is the expected compound annual growth rate (CAGR) for the China Equine Healthcare Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 17.684% from 2025 to 2035.

Which products are driving growth in the China Equine Healthcare Market?

Key products driving the market include vaccines, pharmaceuticals, medicinal feed additives, diagnostics, and software and services.

What will be the market size for vaccines in the China Equine Healthcare Market in 2035?

The market for vaccines is expected to reach 150.0 million USD by 2035.

What is the estimated market value for pharmaceuticals in the China Equine Healthcare Market in 2024?

The pharmaceuticals segment is estimated to be valued at 40.0 million USD in 2024.

Who are the key players in the China Equine Healthcare Market?

Major players include Neogen, Huvepharma, Zoetis, Merck Animal Health, and Elanco Animal Health.

How much is the diagnostics market segment valued at in 2024?

The diagnostics segment of the market is valued at 20.0 million USD in 2024.

What growth opportunities exist within the China Equine Healthcare Market?

Emerging trends such as increased pet ownership and advancements in veterinary technologies present significant growth opportunities.

What is the expected valuation of the medicinal feed additives segment in 2035?

The medicinal feed additives segment is projected to be valued at 180.0 million USD by 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions